Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Marre

Showing results (41-50 of 216) with videos related to

Pageof 22
Sort By:
Diabete & Metabolisme|February 1, 1995
[Prevalence of microalbuminuria in French type 2 diabetics followed by their general practitioner]M Marre, A Girault, D Vasmant
Diabete & Metabolisme|March 1, 1991
[Dyslipoproteinemia and diabetic nephropathy]S Suraniti, P Fressinaud, M Marre
Presse Medicale (Paris, France : 1983)|December 19, 1985
[Treatment of arterial hypertension in diabetics. Contribution of converting enzyme inhibitors]P Passa, M Marre, H Leblanc
The American Journal of Clinical Nutrition|January 30, 1999
Microalbuminuria, glomerular filtration rate, and dietary fat and protein intakes in type 1 diabetesB Bouhanick, S Hadjadj, M Marre
Oftalmologicheskii Zhurnal|January 1, 1990
[The study of color vision in children]A E Kliavina, M Marre, B Marre
BMJ (Clinical Research Ed.)|December 14, 1996
Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathyM Marre, G Chatellier, F Alhenc-Gelas
Diabetes & Metabolism|May 25, 2020
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reportsA J Scheen, M Marre, C Thivolet
Bulletin Des Societes D'Ophtalmologie De France|December 1, 1984
[Results of 300 trabeculoretractions and study of the late failures in 150 cases with 1 year of follow-up]F Moulin, G Van Effenterre, J M Marre
Presse Medicale (Paris, France : 1983)|January 20, 1999
[Type 2 diabetes: new therapeutic perspectives]B Bouhanick, G Berrut, P Fressinaud, et al.
Diabete & Metabolisme|November 1, 1987
[New antihypertensive therapy in diabetics]P Passa, M Marre, H Leblanc, et al.
Pageof 22

Showing results (41-50 of 216) with videos related to

Sort By:
Pageof 22
Diabete & Metabolisme|February 1, 1995
[Prevalence of microalbuminuria in French type 2 diabetics followed by their general practitioner]M Marre, A Girault, D Vasmant
Diabete & Metabolisme|March 1, 1991
[Dyslipoproteinemia and diabetic nephropathy]S Suraniti, P Fressinaud, M Marre
Presse Medicale (Paris, France : 1983)|December 19, 1985
[Treatment of arterial hypertension in diabetics. Contribution of converting enzyme inhibitors]P Passa, M Marre, H Leblanc
The American Journal of Clinical Nutrition|January 30, 1999
Microalbuminuria, glomerular filtration rate, and dietary fat and protein intakes in type 1 diabetesB Bouhanick, S Hadjadj, M Marre
Oftalmologicheskii Zhurnal|January 1, 1990
[The study of color vision in children]A E Kliavina, M Marre, B Marre
BMJ (Clinical Research Ed.)|December 14, 1996
Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathyM Marre, G Chatellier, F Alhenc-Gelas
Diabetes & Metabolism|May 25, 2020
Prognostic factors in patients with diabetes hospitalized for COVID-19: Findings from the CORONADO study and other recent reportsA J Scheen, M Marre, C Thivolet
Bulletin Des Societes D'Ophtalmologie De France|December 1, 1984
[Results of 300 trabeculoretractions and study of the late failures in 150 cases with 1 year of follow-up]F Moulin, G Van Effenterre, J M Marre
Presse Medicale (Paris, France : 1983)|January 20, 1999
[Type 2 diabetes: new therapeutic perspectives]B Bouhanick, G Berrut, P Fressinaud, et al.
Diabete & Metabolisme|November 1, 1987
[New antihypertensive therapy in diabetics]P Passa, M Marre, H Leblanc, et al.
Pageof 22